NASDAQ: GERN - Geron Corporation

Yield per half year: +8.85%
Sector: Healthcare

Share chart Geron Corporation


About

Корпорация "Герон", клиническая биофармацевтическая компания на поздней стадии, специализируется на разработке и коммерциализации методов лечения гематологических миелоидных злокачественных новообразований. Он обладает правами на иметелстат, ингибитор теломеразы в клинических испытаниях фазы 2F3, который ингибирует неконтролируемую пролиферацию злокачественных клеток-предшественников при гематологических миелоидных злокачественных опухолях, чтобы уменьшить дисфункциональную продукцию клеток крови и обеспечить восстановление нормальной продукции клеток крови.

More details
Компания была основана в 1990 году со штаб-квартирой в Менло-Парке, штат Калифорния.


P/S 537.41
P/BV 1.83
EV/EBITDA -3.29
EBITDA -0.0717
Цена ао 4.06
Сайт http://www.geron.com
Число акций ао 0.57065 млрд
Выручка 0.00046
Див.доход ао 0
ISIN US3741631036
Валюта usd
IPO date 1996-06-30
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Change price per day: +0.7444% (4.03)
Change price per week: -4.92% (4.27)
Change price per month: -9.98% (4.51)
Change price per 3 month: -14.71% (4.76)
Change price per half year: +8.85% (3.73)
Change price per year: +128.09% (1.78)
Change price per 3 year: +144.58% (1.66)
Change price per 5 year: +170.67% (1.5)
Change price per year to date: +106.09% (1.97)

Underestimation

Title Value Grade
P/S 5513.83 1
P/BV 5.27 2
P/E 0 0
EV/EBITDA -6.85 0
Total: 2.75

Efficiency

Title Value Grade
ROA, % -46.72 0
ROE, % -74.26 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.4297 10
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % -48.48 0
Yield Ebitda, % 166.08 10
Yield EPS, % -3.85 0
Total: 6

Dividend, % Dividend Result of period Buy before Register closing date Payment before
9.46% 0.14 II кв. 2014 18.07.2014 22.07.2014 06.08.2014

Institutions Volume Share, %
RA Capital Management, L.P. 46202425 8.45
Blackrock Inc. 42172679 7.71
Deep Track Capital, LP 29583449 5.41
Vanguard Group Inc 28564574 5.22
State Street Corporation 25625606 4.69
Vivo Capital, LLC 24143681 4.41
Tcg Crossover Management, Llc 23375839 4.27
NEA Management Company, LLC 22776409 4.16
Millennium Management LLC 14730986 2.69
Geode Capital Management, LLC 10943649 2

ETF Share, % Profitability for 1 year, % Dividends, %
Invesco Pharmaceuticals ETF 3.29699 26.888476367271 1.74279
Inspire Small/Mid Cap ETF 0.20412 38.577885952712 1.92038
Range Cancer Therapeutics ETF 3.52974 58.680203045685 0.11955
Virtus LifeSci Biotech Products ETF 1.40732 41.945031712474 0.13953
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.15529 37.61291904149 1.59225
ProShares Ultra Nasdaq Biotechnology 0.17815 58.954326923077 0.85651
BNY Mellon US Small Cap Core Equity ETF 0.12086 37.872537301924 1.75333
iShares ESG Aware MSCI USA Small-Cap ETF 0.06277 39.294631710362 1.49366
First Trust Multi Cap Growth AlphaDEX Fund 0.13264 48.187044451288 1.02425
Fidelity MSCI Health Care Index ETF 0.02946 21.181088923024 1.46057
First Trust Small Cap Growth AlphaDEX Fund 0.6291 51.937052783242 1.22182
First Trust Small Cap Core AlphaDEX Fund 0.31929 38.56717191346 1.87983
ProShares Hedge Replication ETF 0.01588 6.8665973306333 1.47892
Humankind US Stock ETF 0.01046 22.971795629061 1.99919
Invesco Nasdaq Biotechnology ETF 0.27088 29.399255715045 0.8565
iShares Morningstar Small-Cap ETF 0.0513 37.681332167863 1.60498
iShares Morningstar Small-Cap Growth ETF 0.10126 41.553945249597 0.72598
iShares Russell 2000 Growth ETF 0.1409 47.42032299557 0.6026
iShares Russell 3000 ETF 0.00527 37.942616648456 1.43482
iShares Morningstar Small-Cap ETF 0.0513 410.50632631881 1.60498
iShares Morningstar Small-Cap Growth ETF 0.10126 757.51743375174 0.72598
Direxion Daily S&P Biotech Bull 3x Shares 0.36847 5201.8382352941 0.25924
Nuveen ESG Small-Cap ETF 0.17924 36.100211288862 1.41019
Invesco Dorsey Wright Healthcare Momentum ETF 1.49664 56.526768010575 0.12263
Schwab U.S. Small-Cap ETF 0.06131 -30.367553865653 1.51433
Schwab U.S. Broad Market ETF 0.00431 -53.970149253731 1.43354
SPDR Portfolio MSCI Global Stock Market ETF 0.0119 29.55850326668 2.19607
iShares U.S. Tech Breakthrough Multisector ETF 0.04367 46.089448312801 0.73986
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00634 37.307074947524 1.69572
Northern Lights Fund Trust IV 0.6901 45.149744338934 0.49246
ProShares UltraPro Russell2000 0.05859 125.96465921385 1.47873
Vanguard U.S. Momentum Factor ETF 0.08 52.778724259342 1.05834
Vanguard Russell 3000 ETF 0 38.467141890837 1.43817
Vanguard Russell 2000 Growth ETF 0.14 46.764050831914 0.60264
Vanguard Russell 2000 ETF 0.1 41.410408042578 1.48801
Vanguard Russell 2000 Value ETF 0.06 37.067332982641 2.37825
WisdomTree BioRevolution Fund 2.58778 20.081421169504 0.78691
Principal Healthcare Innovators ETF 0.27625 631.79771324797 0.8416
Future Tech ETF 0.27625 412.888593871 0.8416



Head Job title Payment Year of birth
Ms. Melissa A. Kelly Behrs Executive VP of Business Operations & Chief Alliance Officer 753.22k 1964 (60 years)
Ms. Shannon Odam Senior VP & Chief People Officer N/A 1975 (49 years)
Mr. Edward E. Koval Executive VP & Chief Business Officer N/A 1962 (62 years)
Dr. John A. Scarlett M.D. Chairman of the Board, President & CEO 1.53M 1951 (73 years)
Ms. Aron Feingold Vice President of Investor Relations & Corporate Communications N/A
Dr. Faye Feller M.D. Executive VP & Chief Medical Officer N/A 1983 (41 year)
Ms. Michelle J. Robertson Executive VP, CFO, Treasurer and Principal Financial & Accounting Officer N/A 1967 (57 years)
Dr. Andrew J. Grethlein Ph.D. Executive VP & COO 847.2k 1964 (60 years)
Mr. Scott Samuels Executive VP, Chief Legal Officer & Secretary
Mr. James Ziegler M.B.A. Executive VP & Chief Commercial Officer

Address: United States, Foster City, CA , 919 East Hillsdale Boulevard - open in Google maps, open in Yandex maps
Website: http://www.geron.com